Use filters to refine the search results.
Results 1-5 of 5
|23-Nov-2017||Author Correction: The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation||Smith, L; Farzan, R; Ali, S; Buluwela, L; Saurin, AT, et al|
|14-Mar-2017||Protein interactions involving LARP1 in chemotherapy resistant ovarian cancer cells||Stavraka, C; Mura, M; Fischer, R; Thezenas, M-L; Maghami, SG, et al|
|30-Nov-2017||Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.||Martin, L-A; Ribas, R; Simigdala, N; Schuster, E; Pancholi, S, et al|
|16-Aug-2017||p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells||Periyasamy, M; Singh, A; Gemma, C; Kranjec, C; Farzan, R, et al|
|23-Nov-2017||The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation.||Smith, L; Farzan, R; Ali, S; Buluwela, L; Saurin, AT, et al|